The accurate identification of the primary tumor type in primary and metastatic cancer including cancer of unknown or uncertain primary is important in guiding clinician treatment decision John Bridgewater, M.D., University College London Hospital, UCL Cancer Center, one of the UK’s leading experts on CUP and the patient’s treating physician, … (more)
